MedTrace Logo

Probiotics in Functional Dyspepsia

NCT07276009 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-08

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether a multi-strain probiotic can reduce digestive symptoms and improve quality of life in adults with functional dyspepsia. The main questions it aims to answer are:

* Does the probiotic reduce symptoms such as fullness after meals, bloating, stomach discomfort, and early satiation?
* Does the probiotic improve emotional well-being, including stress, anxiety, and mood? Researchers will compare the probiotic to a placebo (a look-alike capsule with no active ingredients) to see if the probiotic truly helps adults with functional dyspepsia.

Participants will:

* Take one capsule of the probiotic or placebo once daily before meals for 60 days
* Complete questionnaires about their digestive symptoms at the start, 1 month, and 2 months
* Complete surveys on stress, anxiety, depression, and quality of life at the start and 2 months
* Attend scheduled study visits for checkups and assessments

Conditions

  • Functional Dyspepsia

Interventions

OTHER

Lactobacillus

5 billion CFU of lactobacilus ans streptococci once daily for 60 days

OTHER

Maltodextrin (Placebo)

Placebo capsules will be given one a day for 60 days

Sponsors & Collaborators

  • Nordic Biotic Sp. z o.o.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-05
Primary Completion
2026-03-01
Completion
2026-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07276009 on ClinicalTrials.gov